Inventor · disambiguated record
Maria Pihlgren
Also filed as: PIHLGREN MARIA
17 granted patents·14 pending applications·213 citations·filing 2007–2021
95Inventor score
Top patents by PatentIndex Score
31 records- 0197US7892544B2Humanized anti-beta-amyloid antibodyAC IMMUNE SA·Filed 2007·Granted Feb 22, 2011·55 cites·26 claims
- 0294US9585956B2Polynucleotides encoding anti-amyloid beta monoclonal antibodiesAC IMMUNE SA·Filed 2015·Granted Mar 7, 2017·8 cites·21 claims
- 0394US8246954B2Methods of treating amyloidosis with humanized anti-beta-amyloid antibodiesPFEIFER ANDREA·Filed 2009·Granted Aug 21, 2012·24 cites·57 claims
- 0493US9175094B2Monoclonal antibodyAC IMMUNE SA·Filed 2013·Granted Nov 3, 2015·9 cites·36 claims
- 0593US8124353B2Methods of treating and monitoring disease with antibodiesPFEIFER ANDREA·Filed 2007·Granted Feb 28, 2012·20 cites·11 claims
- 0692US8796439B2Nucleic acid molecules encoding a humanized antibodyPFEIFER ANDREA·Filed 2012·Granted Aug 5, 2014·15 cites·47 claims
- 0791US8647631B2Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell linesPFEIFER ANDREA·Filed 2010·Granted Feb 11, 2014·16 cites·15 claims
- 0890US8048420B2Monoclonal antibodyAC IMMUNE SA·Filed 2008·Granted Nov 1, 2011·12 cites·36 claims
- 0988US9304138B2Pharmaceutical compositionPFEIFER ANDREA·Filed 2011·Granted Apr 5, 2016·12 cites·27 claims
- 1085US8613923B2Monoclonal antibodyPFEIFER ANDREA·Filed 2008·Granted Dec 24, 2013·7 cites·12 claims
- 1184US10100104B2Methods of diagnosing tau-protein-associated diseaseUNIV LEUVEN KATH·Filed 2016·Granted Oct 16, 2018·4 cites·26 claims
- 1284US10066010B2Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising TauAC IMMUNE SA·Filed 2016·Granted Sep 4, 2018·4 cites·14 claims
- 1384US9403902B2Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibodyPFEIFER ANDREA·Filed 2008·Granted Aug 2, 2016·7 cites·9 claims
- 1484US9146244B2Polynucleotides encoding an anti-beta-amyloid monoclonal antibodyPFEIFER ANDREA·Filed 2011·Granted Sep 29, 2015·6 cites·37 claims
- 1582US9540434B2Phosphospecific antibodies recognising tauAC IMMUNE SA·Filed 2012·Granted Jan 10, 2017·5 cites·17 claims
- 1681US9657091B2Humanized tau antibodyAC IMMUNE SA·Filed 2013·Granted May 23, 2017·5 cites·22 claims
- 1778US9598485B2Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2014·Granted Mar 21, 2017·4 cites·66 claims
- 1867US2021317197A1Humanized antibodyAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 1965US2022227847A1Humanized antibodyAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 2064US2020055928A1Humanized antibodyAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 2162US2009155249A1Humanized antibody igg1GENENTECH INC·Filed 2008·Application pending·0 cites
- 2259US2015259406A1Pharmaceutical Composition of an Antigenic Tau Peptide Reconstituted in a Liposome and Related Antibodies and Cell LinesAC IMMUNE SA·Filed 2014·Application pending·0 cites
- 2359US2018327485A1Humanized antibodyAC IMMUNE SA·Filed 2017·Application pending·0 cites
- 2458US2010297013A1Humanized antibodyPFEIFER ANDREA·Filed 2008·Application pending·0 cites
- 2557US2014255412A1Pharmaceutical Composition of an Antigenic Tau Peptide Reconstituted in a Liposome and Related Antibodies and Cell LinesUNIV LEUVEN KATH·Filed 2013·Application pending·0 cites
- 2655US2019031746A1Humanized antibody igg1AC IMMUNE SA·Filed 2018·Application pending·0 cites
- 2750US2010297012A1Humanized antibodyPFEIFER ANDREA·Filed 2008·Application pending·0 cites
- 2849US2016244514A1Humanized AntibodyGENENTECH INC·Filed 2015·Application pending·0 cites
- 2948US2016168234A1Humanized antibody igg1AC IMMUNE SA·Filed 2015·Application pending·0 cites
- 3043US2016272699A1Humanized antibodyAC IMMUNE SA·Filed 2015·Application pending·0 cites
- 3136US2010285108A1Method for therapeutic useAC IMMUNE SA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →